AI support for therapy selection, personalized medicine, care pathways, and multidisciplinary treatment planning.
AI treatment planning focuses on systems that help clinicians compare therapeutic options, personalize care pathways, and evaluate next steps across complex cases. These workflows often involve multidisciplinary review, which makes evidence quality, explainability, and human oversight central to safe use.
This section tracks where treatment-planning AI is most relevant, how recommendations are validated, what implementation constraints matter, and how clinicians should judge the difference between supportive insight and unsupported automation.
AI drug discovery tools are moving from early target and compound work into clinical research, real-world data, trial design, and regulatory evidence. The useful question is how each AI output becomes credible enough to support a drug development decision.